Diabetes insipidus

Last updated: September 12, 2024

Diabetes insipidus

nclex

nclex

NCLEX Q&A with Jannah Amiel
Extrinsic hemolytic normocytic anemia: Pathology review
Heart blocks: Pathology review
Malabsorption syndromes: Pathology review
Dyslipidemias: Pathology review
Pituitary tumors: Pathology review
Pericardial disease: Pathology review
Multiple endocrine neoplasia: Pathology review
Peripheral artery disease: Pathology review
Theoretical Foundations of Nursing
Study for Success: Habits Every Nursing Student Should Adopt
Major depressive disorder
Bipolar and related disorders
Suicide
Schizophrenia
Delirium
Cluster C personality disorders
Cluster B personality disorders
Cannabis use disorder
Cocaine use disorder
Narcolepsy (NORD)
Mood disorders: Pathology review
Personality disorders: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Eating disorders: Pathology review
Psychiatric emergencies: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Atypical antipsychotics
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Fat-soluble vitamin deficiency and toxicity: Pathology review
Huntington disease
Cri du chat syndrome
Marfan syndrome
Sickle cell disease (NORD)
Myocardial infarction
Peripheral artery disease
Hypertension
Tetralogy of Fallot
Heart failure
Myocarditis
Atherosclerosis and arteriosclerosis: Pathology review
Shock: Pathology review
Diabetes mellitus
Diabetic nephropathy
Diabetes insipidus and SIADH: Pathology review
Sleep apnea
Celiac disease
Crohn disease
Ulcerative colitis
Bowel obstruction
Jaundice
Neonatal hepatitis
Iron deficiency anemia
Chronic leukemia
Coagulation disorders: Pathology review
Anaphylaxis
Asthma
Candida
Osteomyelitis
Osteoarthritis
Scleroderma
Epidural hematoma
Shaken baby syndrome
Seizures and epilepsy
Frontotemporal dementia
Multiple sclerosis
Guillain-Barre syndrome
Seizures: Pathology review
Hypermagnesemia
Hypercalcemia
Hyponatremia
Chronic kidney disease
Electrolyte disturbances: Pathology review
Benign prostatic hyperplasia
Placenta previa
Placental abruption
Gestational diabetes
Gestational hypertension
Postpartum hemorrhage
Miscarriage
Sudden infant death syndrome
Acute respiratory distress syndrome
Pulmonary embolism
Pharmacokinetics: Drug elimination and clearance
Drug administration and dosing regimens
Cholinomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Class III antiarrhythmics: Potassium channel blockers
Lipid-lowering medications: Statins
Insulins
Anticoagulants: Heparin
Anticoagulants: Warfarin
Glucocorticoids
Sympathomimetics: Direct agonists
Neuromuscular blockers
Uterine stimulants and relaxants
Medication overdoses and toxicities: Pathology review
Normal heart sounds
Oxytocin and prolactin
Thyroid hormones
Insulin
Synthesis of adrenocortical hormones
Phosphate, calcium and magnesium homeostasis
Erythropoietin
Respiratory acidosis
Metabolic acidosis
Pregnancy
Breastfeeding
Pulmonary shunts
Renin-angiotensin-aldosterone system
Calcium channel blockers
Thiazide and thiazide-like diuretics
Positive inotropic medications
Lipid-lowering medications: Fibrates
Antidiuretic hormone
Hypoglycemics: Insulin secretagogues
Acid reducing medications
Pyloric stenosis
Graft-versus-host disease
Myasthenia gravis
Autoimmune hemolytic anemia
Food allergy
Vaccinations
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Febrile seizure
Brain herniation
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Nonbenzodiazepine anticonvulsants
Opioid antagonists
Acid-base map and compensatory mechanisms
Metabolic alkalosis
Ventilation-perfusion ratios and V/Q mismatch
Emphysema
Respiratory alkalosis
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Pharmacokinetics: Drug absorption and distribution
Adrenergic antagonists: Presynaptic
Selective serotonin reuptake inhibitors
Atypical antidepressants
Cell wall synthesis inhibitors: Penicillins
Hepatitis medications
Migraine medications
Osmotic diuretics
Androgens and antiandrogens
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Puberty and Tanner staging
Carbon dioxide transport in blood

Transcript

Watch video only

With diabetes insipidus, “diabetes” means an increased passing of urine, and “insipidus” means tasteless; so diabetes insipidus is a condition characterized by the production of large quantities of dilute and tasteless urine.

The tasteless urine of diabetes insipidus distinguishes it from diabetes mellitus which describes sweet tasting urine- and, yes, urine was really tasted at one point in time to make that distinction!

Now, in the brain there’s a region called the hypothalamus.

Inside the hypothalamus are osmoreceptors, which can sense the osmolality of the blood, or how concentrated it is.

Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood.

There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milli Osmoles per kilogram.

During periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases.

The osmoreceptors in the hypothalamus detect the increased osmolality and that triggers the sensation of thirst, which tells us to drink more water. The water then gets absorbed and dilutes the blood, bringing the osmolality back to normal.

In addition to osmoreceptors, the hypothalamus also contains a cluster of neurons that are found in a specific spot called the supraoptic nucleus.

These neurons produce a hormone called antidiuretic hormone, or ADH. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases blood resistance and raises blood pressure.

When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH down the supraoptico-hypophyseal tract, which runs through the infundibulum or pituitary stalk, and into the posterior pituitary gland, where it is then released into the blood.

ADH travels to the kidneys, specifically to the distal convoluted tubule and collecting ducts of the nephrons and binds to a receptor called vasopressin receptor 2, or AVPR2.

When AVPR2 is bound, proteins called aquaporins, which usually sit in vesicles inside the cells of the distal convoluted tubule and collecting ducts, start to embed themselves in the apical surface of the cells, which is the side facing the lumen of the tubule.

These aquaporins ultimately allow water -- and only water -- to travel out of the lumen of the tubule and into the cells lining the nephron, and ultimately back into the blood. Just like drinking more water, this dilutes the blood, and returns plasma osmolality to a normal level.

However, this reabsorption process also decides how much water leaves the body as urine, and how concentrated the urine is, which is one of the things that keeps a normal urine osmolality between 300 and 900 milli Osmoles per kilogram.

Diabetes insipidus is when the kidneys reabsorb too little water from the lumen of the tubule, causing the body to produce unusually large quantities of urine, which is called polyuria.

Since there’s less water in the blood, plasma osmolality increases and that triggers thirst and causes an individual to drink a lot, which is called polydipsia.

There are four types of diabetes insipidus, each with its own underlying cause.

The first type is central diabetes insipidus, which is when there’s a problem in the hypothalamus or pituitary gland preventing ADH production or release. As a result, there’s insufficient ADH in the blood, and that means there is less vasoconstriction, and that there are insufficient aquaporins in the kidneys.

Central diabetes insipidus is often caused by damage to the hypothalamus osmoreceptors, the supraoptic nucleus, or the supraoptico-hypophysial tract, but in other cases, the exact cause is hard to identify.

The second type is nephrogenic diabetes insipidus, which is when there’s a problem with the kidneys themselves, which makes them unresponsive to ADH. That can happen due to a genetic defect which can lead to abnormal vasopressin receptors or aquaporin proteins that are unresponsive to ADH.

In addition, there are medications like lithium that can decrease the production of aquaporin proteins in the collecting duct.

Finally, there are kidney disorders like polycystic kidney disease that can cause diabetes insipidus.

The third type is gestational diabetes insipidus, which occurs when the placenta of a pregnant woman releases an enzyme called vasopressinase that breaks down vasopressin or ADH. As a result, ADH might still be produced and released as normal, but it doesn’t get to exert its full effect on the blood vessels or kidneys.

In women with gestational diabetes insipidus, vasopressinase is produced starting in week 8 of pregnancy, and peaks in the third trimester. As a result, the symptoms typically worsen during the course of the pregnancy right up until birth when the placenta is removed, but can continue for up to two months after birth due to residual vasopressinase.

Key Takeaways

Diabetes insipidus is when the body cannot regulate its fluid levels properly and loses a lot of water in the urine. There are two major types of diabetes insipidus, which are central and nephrogenic diabetes insipidus. Central diabetes insipidus occurs when the hypothalamus is not producing enough antidiuretic hormone (ADH). ADH ensures that the kidneys produce less urine and reduce water loss. On the other hand, nephrogenic diabetes insipidus results from the kidneys failing to respond to ADH. People with diabetes insipidus present with excessive quantities of diluted urine (polyuria), resulting in excessive thirst (polydipsia).

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "THE PATHOGENESIS OF DIABETES INSIPIDUS." Journal of the American Medical Association (1907)
  7. "Management of Hypopituitarism" Journal of Clinical Medicine (2019)
  8. "Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?" Frontiers in Endocrinology (2018)